Government of Tatarstan Report issue

Government Phase 2 Phase 3

Organization Overview

First Clinical Trial
2013
NCT02104830
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan | State public health institution Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Tatarstan

Active Ingredients

Drugs in Phase 3 Trials (2)

empegfilrastim (1 trial)

sargramostim (leukine) (1 trial)

Drugs in Phase 2 Trials (2)

cefepime (maxipeme) (1 trial)

ftortiazinon (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Infections (Phase 2)

Neutropenia (Phase 3)

Pseudomonas Infections (Phase 2)

Urinary Tract Infections (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4